Small Cap
Indices Fail to Tell the Story of This Market
Stay focused on sectors and rotational action if you want to navigate the action.
Jim Cramer: What Happened to the Gods of Momentum?
When GameStop filed to sell 3.5 million shares, the notion that Ryan Cohen had something up his sleeve went out the window.
It's Even Worse Than the Indexes Look
It's a tough day for many stocks -- but here's my take on the action and how to be best positioned.
I've Got Wine and Baseball Cards on My Mind
Two new IPOs are on my radar.
Liquidity Dries Up and Small-Caps Are Slammed
There is some very ugly action under the surface.
Market's 'Superficial' Highs Are Only Skin Dip
You can't call this market overbought when so much of it isn't participating.
Making the Best of the Peculiar Market Action
Trading in biotech stocks and a particular SPAC play are on my mind.
Small-Caps Pop Back to Life
Special purpose acquisition companies also perk up.
Shark Bites: Taking Advantage of Weak Biotechnology Action
The stock is trading near its recent secondary pricing and has very attractive price targets from analysts.
Why We Raised Our Market Outlook
Can the market break out from its recent pause?